The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
NAFLD as a driver of chronic kidney disease
Abstract
Non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD) are worldwide public health problems, affecting up to 25-30% (NAFLD), and up to 10-15% (CKD) of the general population. Recently, it has also been established that there is a strong association between NAFLD and CKD, regardless of the presence of potential confounding diseases such as obesity, hypertension and type 2 diabetes. Since NAFLD and CKD are both common diseases that often occur alongside other metabolic conditions, such as type 2 diabetes or metabolic syndrome, elucidating the relative impact of NAFLD on the risk of incident CKD presents a substantial challenge for investigators working in this research field. A growing body of epidemiological evidence suggests that NAFLD is an independent risk factor for CKD and recent evidence also suggests that associated factors such as metabolic syndrome, dysbiosis, unhealthy diets, platelet activation and processes associated with ageing could also contribute mechanisms linking NAFLD and CKD. This narrative review provides an overview of the literature on: a) the evidence for an association and causal link between NAFLD and CKD and b) the underlying mechanisms by which NAFLD (and factors strongly linked with NAFLD) may increase the risk of developing CKD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Still, there is uncertainty as to whether there is a direct causal link between MASLD and CKD as both diseases share common risk factors. 227”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [227]
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
Hill, N. R., Fatoba, S., Oke, J. L., Hirst, J. A., O’Callaghan, C. A., Lasserson, D. S., & Hobbs, R. F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158765 · Cited by 4,320
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,162
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 449
Lin, H., Loi, P. L., Ng, J., Shen, L., Teo, W., Chung, A., Raj, P., & Chang, J. P.-E. (2024) · JGH Open · doi:10.1002/jgh3.13098 · Cited by 9
Jung, C., Lee, J. I., Ahn, S. H., Kim, S. U., & Kim, B. S. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18213 · Cited by 9
Yang, F., Wang, W., Qiu, F., Qing, R., Gao, Q., Yan, X., Wu, D., Hui, H., Dang, R., Jiang, G., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-025-01436-1 · Cited by 9
Association between circulating cystatin C and hyperuricemia: a cross-sectional study
Guo, Y., Huang, H., Chen, Y., Shen, C., & Xu, C. (2022) · Clinical Rheumatology · doi:10.1007/s10067-022-06139-6 · Cited by 9
Liu, X., Li, Y., Chai, Y., Zhang, Y., Zhang, L., & Zhang, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1285249 · Cited by 9
Shaji, N., Singhai, A., Sarawagi, R., Pakhare, A. P., Mishra, V. N., & Joshi, R. P. (2022) · Cureus · doi:10.7759/cureus.22682 · Cited by 9
Risk Prevention and Health Promotion for Non-Alcoholic Fatty Liver Diseases (NAFLD)
Khan, A., Ross, H. M., Parra, N. S., Chen, S. L., Chauhan, K., Wang, M., Yan, B. M., Magagna, J., Beiriger, J., Shah, Y., et al. (2022) · Livers · doi:10.3390/livers2040022 · Cited by 9
The LIDPAD Mouse Model Captures the Multisystem Interactions and Extrahepatic Complications in MASLD
Low, Z. S., Chua, D., Cheng, H. S., Tee, R., Tan, W., Ball, C., Sahib, N. B. E., Ng, S. S., Qu, J. T., Liu, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202404326 · Cited by 8
Liu, S.-Y., Huang, C., Huang, S., Liao, T., Kuo, N.-R., Yang, Y., Li, T., Liu, C., Hou, M., & Lin, H. (2021) · Cells · doi:10.3390/cells10113044 · Cited by 9
Yan, Q., Zhao, Z., Liu, D., Li, J., Pan, S., Duan, J., Dong, J., & Liu, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1032814 · Cited by 8
Bianco, A., Franco, I., Curci, R., Bonfiglio, C., Campanella, A., Mirizzi, A., Fucilli, F., Giovanni, G. D., Giampaolo, N., Pesole, P. L., et al. (2023) · Nutrients · doi:10.3390/nu15102252 · Cited by 8
Caussy, C., Rieusset, J., & Koppe, L. (2025) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000732 · Cited by 9
Wu, J., Wu, G., Li, J., Yi, B., Jia, Q., Ju, K., Shi, Q., Wang, Z., Xiao, X., Guo, B., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf103 · Cited by 8
Kim, D. W., Son, M., Lee, H. J., Choi, C. H., Kang, Y. W., Moon, S. Y., Koh, M., Lee, J. Y., Baek, Y. H., & An, W. S. (2025) · Hepatology Research · doi:10.1111/hepr.14226 · Cited by 9
Steatotic Liver Disease in Older Adults: Clinical Implications and Unmet Needs
Clayton‐Chubb, D., Kemp, W. W., Majeed, A., Lange, P. W., Fitzpatrick, J. A., Vaz, K., Lubel, J. S., Hodge, A. D., Ryan, J. L., McNeil, J. J., et al. (2025) · Nutrients · doi:10.3390/nu17132189 · Cited by 12
Liang, J., Liang, Y., Chen, L., Cai, M., Li, S., He, L., Xu, Y., Tan, Y., Li, L., Wu, X., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1675899 · Cited by 8
Abbate, M., Parvanova, A. I., López‐González, Á. A., Yáñez, A. M., Bennasar‐Veny, M., Ramírez‐Manent, J. I., Reseghetti, E., & Ruggenenti, P. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3810 · Cited by 8
Wnt/β-Catenin Pathway Proteins in End-Stage Renal Disease
Al‐Hakeim, H. K., Asad, H. N., & Maes, M. H. J. (2021) · Biomarkers in Medicine · doi:10.2217/bmm-2021-0177 · Cited by 8
The Troubling Link Between Non-alcoholic Fatty Liver Disease (NAFLD) and Extrahepatic Cancers (EHC)
Venniyoor, A., Farsi, A. M. A., & Bahrani, B. J. A. (2021) · Cureus · doi:10.7759/cureus.17320 · Cited by 8
Pellicori, P., Vaduganathan, M., Ferreira, J. P., Zannad, F. M., & Sanyal, A. J. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101281 · Cited by 8
Hassouneh, R., Patel, S. S., Shen, S., Bui, A. T., Syed, T., Flynn, S. M., Patel, V. A., Muthiah, M. D., Sharma, A. K., Bhati, C. S., et al. (2022) · Liver Transplantation · doi:10.1002/lt.26425 · Cited by 8
Asaturyan, H. A., Basty, N., Thanaj, M., Whitcher, B. J., Thomas, E. L., & Bell, J. D. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273171 · Cited by 9
Ou, H., Kawaguchi, S., Sonomura, K., Kawaguchi, T., Kitada, S., Yoshiji, S., Brial, F., Gauguier, D., Xia, J., & Matsuda, F. (2023) · Scientific Reports · doi:10.1038/s41598-023-40697-2 · Cited by 7
Wang, Z., Jin, Z., & Xiong, Z.-F. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16653 · Cited by 7
A prediction model of CKD progression among individuals with type 2 diabetes in the United States
Lin, Y., Shao, H., Fonseca, V. A., Anderson, A. H., Batuman, V., & Shi, L. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108413 · Cited by 7
Saigo, Y., Sasase, T., Tohma, M., Uno, K., Shinozaki, Y., Maekawa, T., Sano, R., Miyajima, K., & Ohta, T. (2023) · Physiological Research · doi:10.33549/physiolres.934981 · Cited by 7
Sheptulina, A. F., Liusina, E. O., Mamutova, E. M., Yafarova, A. A., Kiselev, A. R., & Drapkina, O. M. (2024) · Diagnostics · doi:10.3390/diagnostics14202301 · Cited by 10
Sivaraj, R., Jaikumar, S., & Sengottuvelu, S. (2022) · Comparative Clinical Pathology · doi:10.1007/s00580-022-03321-9 · Cited by 7
Mantovani, A., Zusi, C., Csermely, A., Taverna, A., Cappelli, D., Pagani, M., Valenti, L. V. C., Maffeis, C., & Targher, G. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.03.004 · Cited by 7
Chung, G. E., Han, K., Lee, K., Bae, J. H., Yang, S. Y., Choi, S., Yim, J. Y., & Heo, N. J. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2023.101454 · Cited by 7
Clough, G. F., Chipperfield, A. J., Thanaj, M., Scorletti, E., Calder, P. C., & Byrne, C. D. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00551 · Cited by 7
Huang, T., Wu, I., Lin, C., Shyu, Y., Chen, Y.-C., & Chien, R. (2022) · Biomedical Journal · doi:10.1016/j.bj.2022.04.003 · Cited by 7
Wu, H., He, X., Li, Q., Zheng, Y., Rayamajhi, S., Thapa, A., Meng, G., Zhang, Q. H., Liu, L., Wu, H., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.05.009 · Cited by 7
Zhu, J. F., Zhang, M., Yue, Y., Zhu, J., Li, D., Sun, G., Chen, X., & Zhang, H. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.143555 · Cited by 6
Hupa‐Breier, K. L., Schenk, H. J., Campos-Murguía, A., Wellhöner, F., Heidrich, B., Dywicki, J., Hartleben, B., Böker, C., Mall, J. W., Terkamp, C., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102104 · Cited by 6
Maior, M. D. R. M. S., Ribeiro, N. D. L. I., Silva, H. V. V., Lopes, E. P., & Costa, E. C. (2025) · Biomedicines · doi:10.3390/biomedicines13092162 · Cited by 7
Wang, W., Liu, Y., Yuan, D., Yang, Y., Yang, Y., Ji, D., Pan, Y., Zhang, Y., Xu, J., Guo, H., et al. (2025) · Public Health · doi:10.1016/j.puhe.2025.106020 · Cited by 7
Sriperumbuduri, S., Saravanan, P. B., Gupta, G., & Sanyal, A. J. (2025) · Kidney International Reports · doi:10.1016/j.ekir.2025.103757 · Cited by 7
MASLD prevalence, incidence and global aspects
Wild, S. H., Lazarus, J. V., Spearman, C. W., Ocama, P., Bilson, J., Zhou, X., Zheng, M., & Byrne, C. D. (2026) · Diabetologia · doi:10.1007/s00125-026-06726-1 · Cited by 11
Xiao, Y., Xu, S., Hu, W., Huang, J., Jiang, D., Na, R., Yin, Z., Zhang, J., & Chen, H. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101750 · Cited by 8
Ryu, T., Chae, S. Y., Lee, J. J., Han, J. W., Yang, H. S., Chung, B. S., & Yang, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-92858-0 · Cited by 6
Non-Alcoholic Steatohepatitis Severity Associates with FGF21 Level and Kidney Glucose Uptake
Sarkar, S., Chen, D., Spencer, B. A., Situ, X., Afkarian, M., Matsukuma, K. E., Corwin, M. T., & Wang, G. (2021) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0055 · Cited by 6
Adrian, T., Sørensen, I. M. H., Knop, F. K., Bro, S., Ballegaard, E. L. F., Nordestgaard, B. G., Fuchs, A., Kofoed, K. F., Kühl, J. T., Sigvardsen, P. E., et al. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab266 · Cited by 8
Ultrasound and biomarker based assessment of hepatic steatosis in patients with severe obesity
Byra, M., Szmigielski, C. A., Kalinowski, P., Paluszkiewicz, R., Ziarkiewicz‐Wróblewska, B., Zieniewicz, K., & Styczyński, G. (2022) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16343 · Cited by 6
Rivera‐Esteban, J., Pons, M., Planas, A., Manzano-Núñez, R., Hernández, C., Simó‐Servat, O., Bañeras, J., Soler, M. J., Serón, D., Boixadera, A., et al. (2022) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2022.11.001 · Cited by 6
Chronic kidney disease in nonalcoholic fatty liver disease at primary healthcare centers in Korea
Nah, E., Shin, S. K., Cho, S., Park, H., Kim, S., Kwon, E., & Cho, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0279367 · Cited by 6
Heerkens, L., van Westing, A. C., Voortman, T., Kardys, I., Boersma, E. H., & Geleijnse, J. M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1240099 · Cited by 6
Effect of MAFLD on albuminuria and the interaction between MAFLD and diabetes on albuminuria
Liu, Y., Chai, S., & Zhang, X.-M. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13501 · Cited by 7
Targeting metabolic-associated fatty liver disease in diabetic kidney disease: A call to action
Benlloch, S., Moncho, F., & Górriz, J. L. (2024) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2024.03.009 · Cited by 6
Ismail, H., Mubashar, Z., Khan, H., Naveed, Z., Dilshad, E., Bhatti, M. Z., Anwaar, S., Saleem, S., Mehmood, S., Rahman, A., et al. (2024) · Metabolites · doi:10.3390/metabo14080442 · Cited by 6
Mantovani, A., Beatrice, G., Petracca, G., Pampagnin, F., Sandri, D., & Targher, G. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00008 · Cited by 6
Chronic Kidney Disease After Liver Transplantation
Minjares, R. O., Martin, P. B., & Carrion, A. F. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.01.006 · Cited by 6
Jung, C., Chun, H. S., Lee, M., Koh, H. B., Park, K. H., Joo, Y. S., Kim, H. W., Ahn, S. H., Park, J. T., & Kim, S. U. (2022) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101362 · Cited by 6
Janini, E., Fteiha, B., Ramlawi, I., & Mahamid, M. (2022) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.11.010 · Cited by 6
Update on cardiovascular risk in nonalcoholic fatty liver disease
Johnston, M. P., Patel, J., & Byrne, C. D. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000861 · Cited by 6
Chen, C., He, Y., Ni, Y., Tang, Z., & Zhang, W. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18156 · Cited by 5
Bai, N., Ying, T., Li, D., & Liu, A. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1518540 · Cited by 5
Modulation of liver lipid metabolic pathways by central nervous system ER stress
Kim, H. R., Tabiatnejad, P., Arestakesyan, H., & Young, C. N. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00392.2024 · Cited by 6
Gong, X., Bai, S., Lei, E., Lu, T., Chen, Y., Cai, J., & Liu, J. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1468788 · Cited by 5
He, Y., Zhang, F., Zhang, Z., Zhang, X., & Zhong, Y. (2025) · Annals of Hepatology · doi:10.1016/j.aohep.2025.102115 · Cited by 5
Obesity as a modifiable risk factor in patients with chronic kidney disease
Morales, E., Jenssen, T. G., Bevc, S., Miglinas, M., Martin, W. P., Theodorakopoulou, M. P., Jørgensen, M. B., & Trillini, M. (2025) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaf231 · Cited by 8
Georgakopoulou, V., Steiropoulos, P., Androutsakos, T., Karabella, I., Reppas, K., Cholongitas, E., & Dalamaga, M. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00713-8 · Cited by 5
Epicardial and liver fat implications in albuminuria: a retrospective study
Perdomo, C. M., Martín‐Calvo, N., Ezponda, A., Mendoza, F. J., Bastarrika, G., Garcı́a-Fernández, N., Herrero, J. I., Colina, I., Escalada, J., & Frühbeck, G. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02399-5 · Cited by 5
Lai, M., Lai, J. C., Allegretti, A. S., Patidar, K. R., & Cullaro, G. (2024) · Kidney360 · doi:10.34067/kid.0000000569 · Cited by 5
Pădureanu, V., Dop, D., Radu, L., Rădulescu, D., Pădureanu, R., Pîrșcoveanu, D. F. V., & Caragea, D. C. (2025) · Metabolites · doi:10.3390/metabo15040272 · Cited by 5
Zhao, H., Fang, Y., Zhao, J. Y., Yang, N., Li, Y., Liu, F., & Chen, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-10765-w · Cited by 5
Ren, H., Hu, M., Yan, Y., Cheng, M., Yang, C., Yuan, G., & Du, T. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112927 · Cited by 5
Association of serum creatinine with hepatic steatosis and fibrosis: a cross-sectional study
Ma, J., Wei, Z., Wang, Q., Lu, X., Zhou, Z.-H., Li, R., Shu, Q., Liu, Y., Wang, J., Liu, N., et al. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02437-0 · Cited by 5
Koshino, A., Oshima, M., Arnott, C. G., Fletcher, R. A., Bakris, G. L., Jardine, M., Mahaffey, K. W., Perkovic, V., Pollock, C. A., Heerspink, H. J. L., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14978 · Cited by 5
Wang, Z., Huang, Y., Zhu, M., Cao, J., & Xiong, Z. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.05.038 · Cited by 5
Are we ready for genetic testing in metabolic dysfunction‐associated steatotic liver disease?
Tulone, A., Pennisi, G., Ciccioli, C., Infantino, G., Mantia, C. L., Cannella, R., Mercurio, F., & Petta, S. (2024) · United European Gastroenterology Journal · doi:10.1002/ueg2.12556 · Cited by 5
Sabet, N. H., & Wyatt, T. A. (2024) · Alcohol · doi:10.1016/j.alcohol.2024.12.003 · Cited by 6
Wang, X., Yan, C., Wang, S., Zhu, H., Cao, C., Wu, L., Wang, S., Hu, J., & Zhang, H. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i7.109067 · Cited by 5
Sessa, A. D., Guarino, S., Melone, R., Simone, R. F. D., Marzuillo, P., & del Giudice, E. M. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i34.5793 · Cited by 5
Mantovani, A., Beatrice, G., Stupia, R., & Dalbeni, A. (2020) · Hepatoma Research · doi:10.20517/2394-5079.2020.75 · Cited by 5
Kwon, H. C., Song, J. J., Park, Y., & Lee, S. (2021) · Clinical and Experimental Medicine · doi:10.1007/s10238-021-00691-2 · Cited by 5
Gut microbiota-based metabolism contributes to the protection of pseudolaric acid B against MAFLD
Song, T., Yang, X., Wang, J., Yin, L., Zhao, X., Wang, N., Xu, Y., Qi, Y., Xiong, C.-Q., & Xu, L. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157235 · Cited by 4
MASLD and the cardiovascular-kidney-liver-metabolic syndrome
Angelidi, A. M., Boutari, C., Kokkorakis, M., Stefanakis, K., Mikhailidis, D. P., Jacob, G., & Mantzoros, C. S. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag023 · Cited by 6
Pathological Connections between Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease
Liu, H., Zhang, C., & Xiong, J. (2022) · Kidney Diseases · doi:10.1159/000527834 · Cited by 5
Shifting perspectives in liver diseases after kidney transplantation
Košuta, I., Ostojic, A., Brajković, A. V., Babel, J., Šimunov, B., Sremac, M., & Mrzljak, A. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i7.883 · Cited by 4
You, Y., Xiong, P., Jiang, W., Zeng, Q., Bai, L., Zhou, T., Lv, X., Tang, H., & Wu, D. (2024) · PeerJ · doi:10.7717/peerj.18459 · Cited by 4
Extrahepatic manifestation of metabolic dysfunction-associated steatotic liver disease
Shenoy, A., Ahmed, A., & Kim, D. (2025) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2025.73 · Cited by 4
Scurt, F. G., Bose, K., Canbay, A. E., Mertens, P. R., & Chatzikyrkou, C. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1402-1502 · Cited by 4
Kasem, H. E., AbdElAtty, E., Yahia, A. M. M., & Abdalla, E. M. (2023) · Egyptian Liver Journal · doi:10.1186/s43066-023-00297-1 · Cited by 4
Badawi, R., Taira, N. S. F. A., Hasby, S. E., Elkhalawany, W. A., Elrefaey, W., Khalaf, N. A., & Okda, H. I. (2024) · Saudi Medical Journal · doi:10.15537/smj.2024.45.10.20240393 · Cited by 4
Targeting Insulin Resistance and Liver Fibrosis: CKD Screening Priorities in MASLD
Yang, T., Yang, B., Yin, J., Hou, C., & Wang, Q. (2025) · Biomedicines · doi:10.3390/biomedicines13040842 · Cited by 7
Ohkoshi-Yamada, M., Kamimura, K., Kimura, A., Tanaka, Y., Nagayama, I., Yakubo, S., Abé, H., Yokoo, T., Sakamaki, A., Kamimura, H., et al. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.07.117 · Cited by 4
Reinson, T., Patel, J., Mathews, M., Fountain, D., Buchanan, R. M., & Byrne, C. D. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00335 · Cited by 5
Kim, Y. J., & Cho, Y. S. (2023) · Genes & Genomics · doi:10.1007/s13258-023-01391-9 · Cited by 4
AYDIN, H., Aydın, H. R., Karaibrahimoğlu, A., & Afşar, B. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/166512 · Cited by 4
Esteatosis hepática metabólica y nefropatía diabética: una llamada a la acción
Benlloch, S., Moncho, F., & Górriz, J. L. (2023) · Nefrología · doi:10.1016/j.nefro.2023.08.005 · Cited by 5
Zheng, T., Wang, X., Kamili, K., Luo, C., Hu, Y. B., Wang, D., Wang, B., Gao, P., & Tian, G. (2024) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2023.2299304 · Cited by 4
Cheng, B., Zhou, A., Wen, G., Yao, X., & Wang, J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6026319 · Cited by 4
Rong, F., Mai, Y., Shou, L., Zhu, X., Li, M., Zhu, L., Sun, X., & Zhao, X. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1502671 · Cited by 3
Fukui, A., Takeshita, K., Nakashima, A., Maruyama, Y., & Yokoo, T. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12010039 · Cited by 3
Liao, Y., Davies, N. A., & Bogle, I. D. L. (2022) · Chemical Engineering Science · doi:10.1016/j.ces.2022.118131 · Cited by 3
Expression and localization of HSD17B13 along mouse urinary tract
Zhang, H., Chang, J., Dai, Z., Wang, Q., Qiao, R., Huang, Y., Ma, B., Jiang, J., Zhu, C., Su, W., et al. (2024) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00069.2024 · Cited by 3
Abdelkhalik, M., Tawil, S., Fouani, A. E., Allakiss, N., Mattar, L., Faour, W. H., & Chatila, R. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306825 · Cited by 3
Raesi, R., Kalbasi, S., Gaeini, A. A., Kashani, M. H. G., & Tajik, K. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998320832240805113238 · Cited by 3
Association between SPISE and NAFLD in patients with type 2 diabetes
Zhao, H., Ji, B., Wang, X., Shi, S., Sheng, J., Ma, X., Ban, B., & Gao, G. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1454938 · Cited by 3
Metadata
- Authors
- Byrne, C. D., & Targher, G.
- Affiliations
- University Hospital Southampton NHS Foundation Trust (GB)
- University of Verona (IT)
- Corresponding author
- Byrne, Christopher D.
- Targher, Giovanni
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 72
- Issue
- 4
- Pages
- 785-801
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W3006576880
- Cited by
- 449
- References
- 144
- Citations by year
- 2026: 45 · 2025: 72 · 2024: 76 · 2023: 85 · 2022: 79 · 2021: 57 · 2020: 34
- FWCI
- 9.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Funders
- NIHR Bristol Biomedical Research Centre (IS-BRC-20004)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- non-alcoholic fatty liver disease, chronic kidney disease, CKD risk factors, metabolic syndrome, dysbiosis, platelet activation, aging, type 2 diabetes, obesity, hypertension, unhealthy diet, pathophysiological mechanisms
- MeSH terms
- Adolescent, Adult, Aging, Child, Diabetes Mellitus, Type 2, Diet, Female, Humans, Male, Middle Aged, Obesity, Risk Factors, Platelet Activation, Comorbidity, Prevalence, Metabolic Syndrome, Renal Insufficiency, Chronic, Young Adult, Dysbiosis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
